Bone Biologics Corporation beat EPS estimates 67% of the time across 3 reported quarters (2 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.39 | $-0.43 | -10.3% | Miss |
| Q12026 FY2026 | $-0.54 | $-0.43 | +20.4% | Beat |
| Q42025 FY2025 | $-0.34 | $-0.14 | +58.8% | Beat |
Back to BBLG overview · BBLG holders · BBLG KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.